已收录 268921 条政策
 政策提纲
  • 暂无提纲
Quetiapine for primary insomnia: Consider the risks
[摘要] The second-generation antipsychotic drug quetiapine (Seroquel) is increasingly being used off-label for treating insomnia in the general population, possibly to avoid standard medications with known addictive qualities and adverse side effects. However, evidence to support using it in this way is scant, and quetiapine is associated with weight gain and other metabolic effects. It must be used cautiously and with appropriate monitoring for adverse effects and abuse.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 卫生学
[关键词]  [时效性] 
   浏览次数:3      统一登录查看全文      激活码登录查看全文